title: Efficacy of serum therapy on the treatment of rats experimentally envenomed by bristle extract of the caterpillar Lonomia obliqua: comparison with epsilon-aminocaproic acid therapy.
abstract: Large number of accidents caused by contact with Lonomia obliqua caterpillars, with hemorrhagic complications, have occurred in southern Brazil. Based on Venezuelan expertise to treat Lonomia achelous envenomation, the use of the antifibrinolytic drug epsilon-aminocaproic acid (EACA) has been indicated to treat L. obliqua envenomation, although no evidence has been presented to justify its use. Specific antivenom (antilonomic serum (ALS)) that neutralizes toxins that cause envenomation was developed. To compare the effectiveness of such treatments, rats were injected i.d. with the bristle extract of L. obliqua caterpillars and treated 15 min, 1 and 6 h after with saline, ALS, EACA, or with both ALS and EACA. ALS elicited fibrinogen recovery and normalization of thrombin time (TT), prothrombin time (PT) and activated partial thromboplastin time (APTT), independent of when it was administered; however, hematocrit was decreased in the group treated later. Saline or EACA-treated groups presented neither fibrinogen recovery nor normalization of hemostatic parameters. A high death rate was observed in the group treated with EACA 15 min after the envenomation. Prolongation of TT and APTT observed in the group treated with EACA and ALS indicated that this association gave no benefit in relation to the group treated solely with ALS. The results presented herein suggest that ALS is the only effective treatment for envenomation caused by contact with Lonomia obliqua caterpillars and indicate that EACA should not be administered in the initial phase of envenomation.
authors.affiliation: Laboratório de Fisiopatologia, Instituto Butantan, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil. lrcg@butantan.gov.br
authors.forename: Luís Roberto C
authors.initials: LR
authors.lastname: Gonçalves
authors.forename: M Cristina C
authors.initials: MC
authors.lastname: Sousa-e-Silva
authors.forename: Sandra C
authors.initials: SC
authors.lastname: Tomy
authors.forename: Ida S
authors.initials: IS
authors.lastname: Sano-Martins
mesh_terms: D015119:Aminocaproic Acid / Q000627:therapeutic use*; D000818:Animals; D001180:Arthropod Venoms / Q000633:toxicity*; D007167:Immunotherapy; D007814:Larva; D008297:Male; D009036:Moths / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
chemical_list: D001180:Arthropod Venoms; D015119:Aminocaproic Acid